About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

LOG IN
LOG IN


H. Rept. 118-523 1 (2024-05-23)

handle is hein.congrecreports/crptxagfe0001 and id is 1 raw text is: AUT-ENTICATED US. GOVERNMENT INFORMATION O 118TH CONGRESS REPORT 2d Session HOUSE OF REPRESENTATIVES 118-523 SECURING AMERICA'S VACCINES FOR EMERGENCIES ACT OF 2023 MAY 23, 2024.-Committed to the Committee of the Whole House on the State of the Union and ordered to be printed Mr. McHENRY, from the Committee on Financial Services, submitted the following REPORT [To accompany H.R. 555] [Including cost estimate of the Congressional Budget Office] The Committee on Financial Services, to whom was referred the bill (H.R. 555) to amend the Defense Production Act of 1950 to en- sure the supply of certain medical materials essential to national defense, and for other purposes, having considered the same, re- ports favorably thereon with an amendment and recommends that the bill as amended do pass. The amendment is as follows: Strike all after the enacting clause and insert the following: SECTION 1. SHORT TITLE. This Act may be cited as the Securing America's Vaccines for Emergencies Act of 2023 or the SAVE Act of 2023. SEC. 2. SECURING ESSENTIAL MEDICAL MATERIALS. (a) STATEMENT OF POLICY.-Section 2(b) of the Defense Production Act of 1950 (50 U.S.C. 4502) is amended- (1) by redesignating paragraphs (3) through (8) as paragraphs (4) through (9), respectively; and (2) by inserting after paragraph (2) the following: (3) authorities under this Act should be used when appropriate to ensure the availability of medical materials essential to national defense, including through measures designed to secure the drug supply chain, and taking into consider- ation the importance of United States competitiveness, scientific leadership and cooperation, and innovative capacity;. (b) STRENGTHENING DOMESTIC CAPABILITY.-Section 107 of the Defense Produc- tion Act of 1950 (50 U.S.C. 4517) is amended- (1) in subsection (a), by inserting (including medical materials) after mate- rials; and (2) in subsection (b)(1), by inserting (including medical materials such as drugs (as defined under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.)), devices, and biological products (as that term is defined in section 49-006